Literature DB >> 19790131

Susceptibility to AA amyloidosis in rheumatic diseases: a critical overview.

Laura Obici1, Sara Raimondi, Francesca Lavatelli, Vittorio Bellotti, Giampaolo Merlini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19790131     DOI： 10.1002/art.24735

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  22 in total

1.  Development of amyloidosis in patients with rheumatoid arthritis under TNF-blocking agents.

Authors:  Raquel Roque; Sofia Ramiro; Ana Cordeiro; Pedro Gonçalves; Silva Da Canas; Maria J Santos
Journal:  Clin Rheumatol       Date:  2011-04-12       Impact factor: 2.980

2.  Importance of serum amyloid-A in Behçet's disease.

Authors:  Mehmet Agilli; Fevzi Nuri Aydin; Yasemin Gulcan Kurt; Tuncer Cayci
Journal:  Clin Rheumatol       Date:  2015-01-14       Impact factor: 2.980

3.  First case of pleural amyloidosis in systemic erythematosus: report and literature review.

Authors:  J Xiong; Y Ren; H Li; B Fu; R Wu
Journal:  Z Rheumatol       Date:  2018-11       Impact factor: 1.372

4.  A case of systemic amyloidosis associated with cyclic neutropenia.

Authors:  HyunKyung Lee; Kyoung Hee Han; Yun Hye Jung; Hee Gyung Kang; Kyung Chul Moon; Il Soo Ha; Yong Choi; Hae Il Cheong
Journal:  Pediatr Nephrol       Date:  2010-12-15       Impact factor: 3.714

5.  Long-term kinetics of AA amyloidosis and effects of inflammatory restimulation after disappearance of amyloid depositions in mice.

Authors:  N Muhammad; T Murakami; Y Inoshima; N Ishiguro
Journal:  Clin Exp Immunol       Date:  2015-04-23       Impact factor: 4.330

6.  Plasma proteomics of differential outcome to long-term therapy in children with idiopathic pulmonary arterial hypertension.

Authors:  Michael E Yeager; Kelley L Colvin; Allen D Everett; Kurt R Stenmark; D Dunbar Ivy
Journal:  Proteomics Clin Appl       Date:  2012-06       Impact factor: 3.494

7.  Divergent effect of glycosaminoglycans on the in vitro aggregation of serum amyloid A.

Authors:  J Javier Aguilera; Fuming Zhang; Julie M Beaudet; Robert J Linhardt; Wilfredo Colón
Journal:  Biochimie       Date:  2014-05-28       Impact factor: 4.079

8.  Anti-interleukin 1 treatment in secondary amyloidosis associated with autoinflammatory diseases.

Authors:  Rezan Topaloglu; Ezgi Deniz Batu; Diclehan Orhan; Seza Ozen; Nesrin Besbas
Journal:  Pediatr Nephrol       Date:  2015-11-12       Impact factor: 3.714

Review 9.  Pathophysiology and treatment of systemic amyloidosis.

Authors:  Julian D Gillmore; Philip N Hawkins
Journal:  Nat Rev Nephrol       Date:  2013-08-27       Impact factor: 28.314

Review 10.  Amyloidosis in alkaptonuria.

Authors:  Lia Millucci; Daniela Braconi; Giulia Bernardini; Pietro Lupetti; Josef Rovensky; Lakshminaryan Ranganath; Annalisa Santucci
Journal:  J Inherit Metab Dis       Date:  2015-04-14       Impact factor: 4.982
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.